Indian experts argue this sort of labelling could be counterproductive to public health in the country, where the risk of stigma associated with mpox may outweigh the potential benefits of targeted interventions Indian experts argue this sort of labelling could be counterproductive to public health in the country, where the risk of stigma associated with mpox may outweigh the potential benefits of targeted interventions Health Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu
Should mpox be labelled a sexually transmitted disease?
